3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Conditions
Smoldering Multiple Myeloma
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Leukemia, Myeloid, Acute
1
Interventions
Cyclophosphamide
89
fludarabine phosphate
77
Mycophenolic Acid
53
Tacrolimus
52
Peripheral Blood Stem Cell Transplantation
50
Busulfan
44
Whole-Body Irradiation
43
Antilymphocyte Serum
41
fludarabine
37
Cyclosporine
36
Filgrastim
32
Melphalan
27
Methotrexate
26
Radiotherapy
23
Cord Blood Stem Cell Transplantation
19
Methylprednisolone
18
Granulocyte Colony-Stimulating Factor
16
Sirolimus
14
Etoposide
13
Alemtuzumab
12
thymoglobulin
11
sargramostim
11
Stem Cell Transplantation
11
Rituximab
11
Thiotepa
9
Azacitidine
8
Cytarabine
7
Psychiatric Rehabilitation
6
Prednisone
6
Flow Cytometry
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
Emulsions
×
Plasma cell
×
Clear all
NCT02240537
2016-04-19
BBMPI03
Benovus Bio, Inc.
Phase 1
Unknown
4 enrolled